BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 12112157)

  • 1. Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.
    Cook IA; Morgan ML; Dunkin JJ; David S; Witte E; Lufkin R; Abrams M; Rosenberg S; Leuchter AF
    Int J Geriatr Psychiatry; 2002 Jul; 17(7):610-8. PubMed ID: 12112157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects.
    Cook IA; Leuchter AF; Morgan ML; Conlee EW; David S; Lufkin R; Babaie A; Dunkin JJ; O'Hara R; Simon S; Lightner A; Thomas S; Broumandi D; Badjatia N; Mickes L; Mody RK; Arora S; Zheng Z; Abrams M; Rosenberg-Thompson S
    Arch Neurol; 2002 Oct; 59(10):1612-20. PubMed ID: 12374500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal progression of subclinical structural brain disease in normal aging.
    Cook IA; Leuchter AF; Morgan ML; Dunkin JJ; Witte E; David S; Mickes L; O'Hara R; Simon S; Lufkin R; Abrams M; Rosenberg S
    Am J Geriatr Psychiatry; 2004; 12(2):190-200. PubMed ID: 15010348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain volumetric MRI study in healthy elderly persons using statistical parametric mapping].
    Miyahira Y; Yu J; Hiramatsu K; Shimazaki Y; Takeda Y
    Seishin Shinkeigaku Zasshi; 2004; 106(2):138-51. PubMed ID: 15052785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of white matter hyperintensities in elderly individuals over 3 years.
    Sachdev P; Wen W; Chen X; Brodaty H
    Neurology; 2007 Jan; 68(3):214-22. PubMed ID: 17224576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study.
    Boccardi M; Ghidoni R; Govoni S; Testa C; Benussi L; Bonetti M; Binetti G; Frisoni GB
    Menopause; 2006; 13(4):584-91. PubMed ID: 16837880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women.
    Archer JS; Love-Geffen TE; Herbst-Damm KL; Swinney DA; Chang JR
    Menopause; 2006; 13(3):528-37. PubMed ID: 16735951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample.
    Wen W; Sachdev PS; Chen X; Anstey K
    Neuroimage; 2006 Feb; 29(4):1031-9. PubMed ID: 16253521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).
    Akisaki T; Sakurai T; Takata T; Umegaki H; Araki A; Mizuno S; Tanaka S; Ohashi Y; Iguchi A; Yokono K; Ito H
    Diabetes Metab Res Rev; 2006; 22(5):376-84. PubMed ID: 16506272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly.
    Sonohara K; Kozaki K; Akishita M; Nagai K; Hasegawa H; Kuzuya M; Yokote K; Toba K
    Geriatr Gerontol Int; 2008 Jun; 8(2):93-100. PubMed ID: 18713161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure and the brain: a 5-year follow-up.
    Goldstein IB; Bartzokis G; Guthrie D; Shapiro D
    Neurology; 2005 Jun; 64(11):1846-52. PubMed ID: 15955932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifelong estrogen exposure and cognitive performance in elderly women.
    Smith CA; McCleary CA; Murdock GA; Wilshire TW; Buckwalter DK; Bretsky P; Marmol L; Gorsuch RL; Buckwalter JG
    Brain Cogn; 1999 Apr; 39(3):203-18. PubMed ID: 10101041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Education, atrophy, and cognitive change in an epidemiological sample in early old age.
    Christensen H; Batterham PJ; Mackinnon AJ; Anstey KJ; Wen W; Sachdev PS
    Am J Geriatr Psychiatry; 2009 Mar; 17(3):218-26. PubMed ID: 19454848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.
    Regenold WT; Hisley KC; Obuchowski A; Lefkowitz DM; Marano C; Hauser P
    J Affect Disord; 2005 Apr; 85(3):341-50. PubMed ID: 15780705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose estradiol alters brain activity.
    Stevens MC; Clark VP; Prestwood KM
    Psychiatry Res; 2005 Aug; 139(3):199-217. PubMed ID: 16084069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly alcohol consumption, brain atrophy, and white matter hyperintensities in a community-based sample aged 60 to 64 years.
    Anstey KJ; Jorm AF; Réglade-Meslin C; Maller J; Kumar R; von Sanden C; Windsor TD; Rodgers B; Wen W; Sachdev P
    Psychosom Med; 2006; 68(5):778-85. PubMed ID: 17012533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease: The PROSPER Study.
    Versluis CE; van der Mast RC; van Buchem MA; Bollen EL; Blauw GJ; Eekhof JA; van der Wee NJ; de Craen AJ;
    Int J Geriatr Psychiatry; 2006 Apr; 21(4):375-81. PubMed ID: 16534770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.